Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 100 Women only

Using human acellular dermal matrix for treating pelvic organ prolapse in women

Official title: Transvaginal Human Acellular Dermal Matrix and Sacrospinous Fixation for Anterior and Apical Prolapse Treatment in Patients With Hiatal Ballooning or Levator Ani Injury: a Randomized Pilot Trial

Run by Hospital Mutua de Terrassa · NCT06404931 · Data updated 2026-11-12

This study is testing three different surgical options to see which one works best for women with pelvic organ prolapse.

More Female trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 100 Years
SexWomen only
Enrollment90 (estimated)
SponsorHospital Mutua de Terrassa
Academic / other
Locations1 site (Terrassa)
StatusRecruiting
StartedJuly 1, 2024
Main results expectedJanuary 1, 2025
Study endsJanuary 1, 2026
Registry record updatedJanuary 17, 2025
Trial IDNCT06404931 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women over 18 with symptomatic anterior and apical prolapse who are eligible for vaginal surgical treatment.

Probably not a fit

Patients with previous pelvic floor surgery, chronic pelvic pain, or advanced prolapse (grade IV) may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of three surgical procedures for treating symptomatic anterior and apical prolapse in women. Participants will be randomly assigned to one of three groups: one receiving a classic vaginal hysterectomy with anterior colporrhaphy, another receiving a vaginal hysterectomy with human acellular dermal matrix reinforcement, and the last receiving vaginal hysterectomy with sacrospinous fixation alone. The study will assess anatomical severity and symptoms using validated questionnaires and 3D ultrasound imaging, with follow-ups scheduled at multiple intervals over three years to monitor outcomes and complications.

Why it matters

Potential benefit: If successful, this study could provide a more effective surgical option for women suffering from pelvic organ prolapse.

How similar studies have gone: Other studies have shown promise in using acellular dermal matrices for surgical reinforcement, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women with symptomatic POP with indication of vaginal surgery.
* Women with hiatal ballooning or levator ani injury evaluated by 3D pelvic floor ultrasound.
* Women ≥18 years old.
* Women wishing to complete a 36-month follow-up.
* Understand and accept the study procedures and sign the informed consent.

Exclusion Criteria:

* Women with previous pelvic floor or prolapse surgery
* Women with POP grade IV
* Women with chronic pelvic pain.
* Not being able to understand the nature of the study and/or the procedures to be followed.
* Not signing the informed consent

Where it's running

  • Hospital Mutua de Terrassa
    Terrassa, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.